HF1399 (Legislative Session 94 (2025-2026))
Commissioner of corrections required to maintain a supply of opiate antagonists to administer to persons who overdose in correctional facilities, and commissioner required to provide training to employees on how to administer opiate antagonists.
Related bill: SF2837
AI Generated Summary
Purpose
The bill would require the Minnesota Department of Corrections to ensure that every correctional facility has a ready supply of opiate antagonists (such as nasal naloxone) to reverse opioid overdoses, and to provide staff training on how to recognize overdoses and administer nasal opiate antagonists. The training would be done in coordination with the state health department.
Main Provisions
- The commissioner must maintain a supply of opiate antagonists at each correctional facility, defined by the bill, and use them in accordance with existing administration rules.
- The commissioner must store an ample number of nasal opiate antagonist doses throughout each facility so staff can respond quickly to overdoses.
- The commissioner, in consultation with the commissioner of health, must train department employees on recognizing the symptoms of an opiate overdose and how to administer nasal opiate antagonists.
How this changes current law
- Establishes a new statutory requirement (OPIATE ANTAGONISTS) for the Department of Corrections.
- Codifies specific requirements to stock nasal opiate antagonists, distribute them across facilities for rapid access, and provide mandated training for staff.
Implementation and scope
- Requires coordination with the Minnesota Department of Health for training.
- References to existing administration and coding provisions (e.g., administration guidelines in section 151.37 subdivision 12 and the definition of opiate antagonists in section 604A.04 subdivision 1).
Significance and potential impact
- Aims to reduce fatalities from opioid overdoses inside correctional facilities by ensuring timely access to reversal medications and trained staff.
- May involve costs for stocking supplies and providing ongoing training, plus alignment with current health and safety protocols.
Terminology and concepts (for quick reference)
- opiate antagonists
- nasal opiate antagonists
- overdose / opioid overdose
- correctional facilities / Department of Corrections
- staff training
- administration guidelines
- consultation with the commissioner of health
- Minnesota Statutes references (604A.04, 151.37)
Relevant Terms - opiate antagonists - nasal naloxone - overdose recognition - correctional facility - Department of Corrections - training - administration - health department coordination - Minnesota Statutes (604A.04, 151.37)
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| February 24, 2025 | House | Action | Introduction and first reading, referred to | Public Safety Finance and Policy | |
| February 26, 2025 | House | Action | Author added | ||
| March 05, 2025 | House | Action | Authors added |
Citations
[
{
"analysis": {
"added": [
"Requires the commissioner to maintain a supply of opiate antagonists defined in 604A.04, subd. 1 at each correctional facility.",
"Requires the commissioner to store ample doses of nasal opiate antagonists throughout facilities for rapid response.",
"Requires training to staff on recognizing overdoses and administering nasal opiate antagonists, in consultation with the commissioner of health, pursuant to 151.37, subd. 12."
],
"removed": [
""
],
"summary": "The bill references Minnesota Statutes 604A.04, subdivision 1 to define opiate antagonists and to authorize correctional facilities to maintain a supply of these antagonists for overdose response.",
"modified": [
""
]
},
"citation": "604A.04",
"subdivision": "subd. 1"
},
{
"analysis": {
"added": [
"Training to be provided to department employees on recognizing overdoses and administering nasal opiate antagonists, in accordance with 151.37, subd. 12."
],
"removed": [
""
],
"summary": "The bill references Minnesota Statutes 151.37, subdivision 12 to govern training related to recognizing opioid overdoses and administering nasal opiate antagonists.",
"modified": [
""
]
},
"citation": "151.37",
"subdivision": "subd. 12"
}
]Progress through the legislative process
In Committee